Japan
About H.U. Group Holdings, Inc.
H.U. Group Holdings, Inc., together with its subsidiaries, operates a diversified healthcare business across Japan, the United States, Europe, and other international markets. Formerly known as Miraca Holdings Inc., the company rebranded in July 2020 and has been a key player in the healthcare industry since its incorporation in 1950. Headquartered in Tokyo, Japan, H.U. Group Holdings delivers innovative solutions through its three core business segments.
Business Segments
-
Lab Testing and Related Services
This segment specializes in specimen collection from medical facilities and conducts a wide range of laboratory tests. It also supports pharmaceutical research and development through precision testing, data management, and logistical services.
-
In Vitro Diagnostics
Offers cerebrospinal fluid reagents, blood-based biomarkers for neurodegenerative diseases (e.g., Alzheimer's), and rapid diagnostic kits for infectious diseases like influenza and COVID-19. The segment also supplies raw materials to global diagnostics companies under a CDMO model and provides the Lumipulse automated immunoassay system.
-
Healthcare-related Services
Provides sterilization services for hospitals, medical equipment maintenance, and logistics management. Additionally, it offers home medical care, nursing services, and rental solutions for nursing care equipment such as wheelchairs and beds.
